Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
gettyimages x

Another Phase III study finds hydroxychloroquine ineffective

Alaric Dearment | 
[H]ydroxychloroquine – the malaria and autoimmune disease drug that President Donald Trump promoted as a potential “game changer” early in ...

Why use gene editing on human embryos when other options are available?

Josh Baxt | 
Researchers in the U.S. and South Korea have shown that gene editing can correct a genetic disorder in an embryo. Using CRISPR-Cas9, ...

Why CRISPR, other academia-produced technologies, should belong to everyone

Juliet Preston | 
Why does anybody own CRISPR? [According to Michael Eisen, Berkeley professor and co-founder of the Public Library of Science] intellectual property in ...

Nanotechnology could lead to revolution in drug development

Meghana Keshavan | 
Monoclonal antibody research skyrocketed in the 1980s. By the next decade, they hit the market and today, some of the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists